Nothing Special   »   [go: up one dir, main page]

NO20032156L - Behandling av angstforstyrrelser - Google Patents

Behandling av angstforstyrrelser

Info

Publication number
NO20032156L
NO20032156L NO20032156A NO20032156A NO20032156L NO 20032156 L NO20032156 L NO 20032156L NO 20032156 A NO20032156 A NO 20032156A NO 20032156 A NO20032156 A NO 20032156A NO 20032156 L NO20032156 L NO 20032156L
Authority
NO
Norway
Prior art keywords
treatment
anxiety disorders
anxiety
disorders
Prior art date
Application number
NO20032156A
Other languages
English (en)
Other versions
NO20032156D0 (no
Inventor
Holly Read Thomasson
David Michelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20032156D0 publication Critical patent/NO20032156D0/no
Publication of NO20032156L publication Critical patent/NO20032156L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20032156A 2000-11-15 2003-05-13 Behandling av angstforstyrrelser NO20032156L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24901000P 2000-11-15 2000-11-15
US26536201P 2001-01-31 2001-01-31
PCT/US2001/027801 WO2002040006A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders

Publications (2)

Publication Number Publication Date
NO20032156D0 NO20032156D0 (no) 2003-05-13
NO20032156L true NO20032156L (no) 2003-05-13

Family

ID=26939750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032156A NO20032156L (no) 2000-11-15 2003-05-13 Behandling av angstforstyrrelser

Country Status (16)

Country Link
EP (1) EP1395253A2 (no)
JP (1) JP2004529073A (no)
KR (1) KR20030051812A (no)
CN (1) CN1822825A (no)
AU (1) AU2002217757A1 (no)
BR (1) BR0115301A (no)
CA (1) CA2426069A1 (no)
CZ (1) CZ20031339A3 (no)
EA (1) EA200300567A1 (no)
HR (1) HRP20030384A2 (no)
IL (1) IL155874A0 (no)
MX (1) MXPA03004190A (no)
NO (1) NO20032156L (no)
PL (1) PL366119A1 (no)
SK (1) SK5422003A3 (no)
WO (1) WO2002040006A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004525912A (ja) * 2001-03-06 2004-08-26 イーライ・リリー・アンド・カンパニー モノアミン取込の阻害剤
US20040092519A1 (en) * 2002-08-14 2004-05-13 Fred Hassan New treatment for hot flashes
GB0309440D0 (en) * 2003-04-25 2003-06-04 Lilly Co Eli Quinolone derivatives
WO2004103356A2 (en) * 2003-05-15 2004-12-02 Eli Lilly And Company Treatment of emotional dysregulation
CN1889940A (zh) * 2003-12-12 2007-01-03 伊莱利利公司 热潮红、冲动控制障碍和全身性医学病症引起的人格变化的治疗
US8440724B2 (en) 2008-01-09 2013-05-14 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US20120220665A1 (en) * 2009-11-03 2012-08-30 Mayo Foundation For Medical Education And Research Inhibiting Neurotransmitter Reuptake
WO2011056788A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US9944618B2 (en) 2013-03-14 2018-04-17 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US11446268B2 (en) * 2019-02-01 2022-09-20 Yamo Pharmaceuticals Llc Compositions and methods for treating anxiety-related disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2931997A (en) * 1996-05-07 1997-11-26 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
KR100948757B1 (ko) * 1999-07-01 2010-03-23 파마시아 앤드 업존 캄파니 엘엘씨 고선택성 노르에피네프린 재흡수 억제제 및 그의 이용 방법

Also Published As

Publication number Publication date
EP1395253A2 (en) 2004-03-10
NO20032156D0 (no) 2003-05-13
AU2002217757A1 (en) 2002-05-27
CZ20031339A3 (cs) 2003-10-15
JP2004529073A (ja) 2004-09-24
PL366119A1 (en) 2005-01-24
HRP20030384A2 (en) 2003-08-31
CA2426069A1 (en) 2002-05-23
SK5422003A3 (en) 2003-12-02
WO2002040006A2 (en) 2002-05-23
CN1822825A (zh) 2006-08-23
BR0115301A (pt) 2004-12-14
IL155874A0 (en) 2003-12-23
MXPA03004190A (es) 2003-09-22
EA200300567A1 (ru) 2004-10-28
WO2002040006A3 (en) 2003-12-24
KR20030051812A (ko) 2003-06-25

Similar Documents

Publication Publication Date Title
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20024273L (no) Terapeutiske anvendelser av PPAR-mediatorer
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
GB0007193D0 (en) Treatment of movrmrnt disorders
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20020062L (no) Behandling av nevrotiske forstyrrelser
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20032156L (no) Behandling av angstforstyrrelser
NO20023425D0 (no) Fremgangsmåte for lindring av angst
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024236D0 (no) Behandling av psoriasis
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20010390D0 (no) Behandling av angstsykdommer
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20024331D0 (no) Behandling av lidelser relatert til det serotonerge system
NO20030767D0 (no) Behandling av forbrenninger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application